Russian Talent War Heats Up For AstraZeneca And Other Big Pharma
This article was originally published in PharmAsia News
AstraZeneca PLC and other Big Pharma companies are staffing up in Russia by increasingly looking for specialized personnel with expertise in sales, government relations, market access, pharmacoeconomics and related fields
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.